Wuyi International Pharmaceutical Company Ltd. provided earnings guidance for the year ended 31 December 2014. The board of directors of the company informed shareholders of the company and potential investors that, based on the information currently available to the group, although there have been improvements in the group's turnover for the year ended 31 December 2014 as compared to the year ended 31 December 2013, the group is expected to record an increase in consolidated net loss for the year ended 31 December 2014 as compared to the consolidated net loss recorded for the year ended 31 December 2013. The Board believes that the group's financial performance has been affected by a drop in gross profit margin of the group mainly for the following reasons: The continuingly increasing pressure in raw material costs, packing material costs and labour costs in the market of the People's Republic of China.